A Biomechanical Assessment of the AST Stabilimax BAR Using Radiostereometric Analysis (RSA)
Launched by STATE UNIVERSITY OF NEW YORK - UPSTATE MEDICAL UNIVERSITY · Mar 4, 2008
Trial Information
Current as of May 13, 2025
Withdrawn
Keywords
ClinConnect Summary
Radiostereometric Analysis, or RSA, is an accurate in vivo measurement technique using two simultaneous radiographs. It provides researchers with three dimensional motion analyses to look not only at routine flexion/extension, but also other rotational and translational changes. The measurement accuracy offered by this technique far exceeds the manual techniques currently used. Utilization of the RSA technology at the IHP and the United States is in its infancy. The investigators have placed much effort over the past 2-3 years to put the necessary dedicated resources and personnel in place....
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects scheduled to have lumbar surgery to receive the AST Stabilimax BAR
- • All subjects must be skeletally mature, between the ages of 18-75
- Exclusion Criteria:
- • Pregnant women will be excluded due to added radiation exposure
- • Prisoners will also be excluded
About State University Of New York Upstate Medical University
The State University of New York - Upstate Medical University is a premier academic institution dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, Upstate Medical University focuses on translating scientific discoveries into effective medical treatments and improving patient outcomes. With a commitment to excellence in clinical research, the university collaborates with multidisciplinary teams to conduct studies that address critical health challenges, ensuring rigorous methodologies and adherence to ethical standards. Through its robust infrastructure and expertise, Upstate Medical University plays a vital role in shaping the future of medicine and enhancing community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Syracuse, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials